Veteran Affairs Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center (GRECC), Nashville, TN, USA.
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Clin Rheumatol. 2020 Jun;39(6):1793-1802. doi: 10.1007/s10067-020-04955-2. Epub 2020 Feb 8.
Patients with rheumatoid arthritis (RA) often receive opioid analgesics for pain management. We examined the association between mental health conditions and the risk of chronic opioid therapy.
A retrospective cohort of veterans with RA initiating opioid use was assembled using Veterans Health Administration databases (2001-2012). Mental health conditions included anxiety (N = 1108, 12.9%), depression (N = 1912, 22.2%), bipolar disease (N = 131, 1.5%), and post-traumatic stress disorder (N = 768, 8.9%) and were identified by ICD coded diagnoses and use of specific medications. Cohort members were followed from opioid initiation through chronic opioid therapy, defined as the continuous availability of opioids for at least 90 days. Multivariable Cox proportional hazard regression models assessed the association between mental health conditions and chronic opioid therapy accounting for relevant covariates. Subgroup analyses examined whether the strength of the observed association varied by the duration of the initial opioid prescription.
We identified 14,767 patients with RA with 22,452 episodes of opioid use initiation. Mental health conditions were identified in 8607 (38.3%) patients. Compared with patients without mental health conditions, patients with mental health conditions have a higher risk of developing chronic opioid therapy (469.3 vs 378.1 per 1000 person-years, adjusted hazard ratio [aHR] 1.18, 95% CI 1.09, 1.29). The increased risk was highest for those with a history of opioid use disorder (aHR 1.94, 95% CI 1.09, 3.46) and also elevated for those with other substance use disorders (aHR 1.35, 95% CI 1.05, 1.73). Duration of the initial opioid prescription was independently associated with chronic opioid therapy, regardless of the estimated opioid daily dose.
History of mental health conditions and duration of the initial opioid prescription were associated with an increased risk of chronic opioid therapy among patients with RA.Key Points• Approximately a third of patients with RA are exposed to opioid analgesics.• Patients with RA and history of mental health disease, especially substance use disorders, who initiate opioid use have an increased risk of chronic opioid therapy.• This study provides insight in an underrepresented population of mainly male patients with RA.
类风湿关节炎(RA)患者常接受阿片类镇痛药来缓解疼痛。我们研究了心理健康状况与慢性阿片类药物治疗风险之间的关系。
使用退伍军人事务部(VA)数据库(2001-2012 年)组建了一个开始使用阿片类药物的 RA 退伍军人的回顾性队列。心理健康状况包括焦虑症(N=1108,12.9%)、抑郁症(N=1912,22.2%)、双相情感障碍(N=131,1.5%)和创伤后应激障碍(N=768,8.9%),通过 ICD 编码诊断和特定药物使用来确定。队列成员从开始使用阿片类药物到慢性阿片类药物治疗(至少 90 天连续提供阿片类药物)进行随访。多变量 Cox 比例风险回归模型评估了心理健康状况与慢性阿片类药物治疗之间的关联,同时考虑了相关协变量。亚组分析检查了观察到的关联强度是否随初始阿片类药物处方的持续时间而变化。
我们确定了 14767 例 RA 患者,其中有 22452 例开始使用阿片类药物。1000 人年中,有 8607 例(38.3%)患者存在心理健康状况。与无心理健康状况的患者相比,有心理健康状况的患者发生慢性阿片类药物治疗的风险更高(469.3 比 378.1/1000 人年,调整后的危险比[aHR]1.18,95%CI 1.09,1.29)。有阿片类药物使用障碍史的患者风险最高(aHR 1.94,95%CI 1.09,3.46),其他物质使用障碍患者的风险也升高(aHR 1.35,95%CI 1.05,1.73)。初始阿片类药物处方的持续时间与慢性阿片类药物治疗独立相关,而与估计的阿片类药物日剂量无关。
RA 患者的心理健康状况史和初始阿片类药物处方持续时间与慢性阿片类药物治疗风险增加相关。